AMBA vs JAZZ · rev $284.9M vs P/E 1988, rev $4.07B
Ambarella Inc (AMBA) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Ambarella Inc (AMBA) is a semiconductor equipment & materials company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported AMBA revenue for 2025-01-31 was $284.9M. Net income was -$117.1M. Revenue was up 25.8% from 2024-01-31 to 2025-01-31. AMBA currently screens at market cap $2.86B.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
AMBA currently screens at market cap $2.86B. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the AMBA and JAZZ stock pages for the full models.
Not investment advice.